October 2010 Briefing - Urology
Here are what the editors at HealthDay consider to be the most important developments in Urology for October 2010. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
BPA Exposure Associated With Poorer Semen Quality
FRIDAY, Oct. 29 (HealthDay News) -- Exposure to bisphenol-A (BPA) -- a component of many consumer products, including plastic containers and liners of food and beverage cans -- may have an adverse effect on semen quality, according to research published online Oct. 29 in Fertility and Sterility.
Men With Cancer Have High Hypogonadism Prevalence
FRIDAY, Oct. 29 (HealthDay News) -- Men with cancer have a high prevalence of hypogonadism and a resulting reduction in quality of life (QoL) and sexual function, according to a study published online Oct. 25 in the Journal of Clinical Oncology.
Obesity May Affect Fertility After Vasectomy Reversal
THURSDAY, Oct. 28 (HealthDay News) -- Obese men who have vasectomy reversal have lower serum testosterone levels and more antisperm antibodies than overweight and normal-weight men, but age of their female partners is the only independent predictor of post-surgery pregnancy, according to research published in the October issue of Urology.
Kidney Stone Risks for Gastric Surgeries Compared
WEDNESDAY, Oct. 27 (HealthDay News) -- Obese patients who undergo gastric banding or sleeve gastrectomy to lose weight are less likely to form kidney stones after the procedure than patients who have the more invasive Roux-en-Y gastric bypass (RYGB) surgery, according to a study in the October issue of Urology.
Primary Care Trails Other Specialties in Hourly Wages
TUESDAY, Oct. 26 (HealthDay News) -- Primary care physicians have substantially lower hourly wages than other specialists, and although most physicians find Medicare reimbursement inequitable, they show little consensus on how to reform it, according to two studies published in the Oct. 25 issue of the Archives of Internal Medicine.
Bacteriuria Unrelated to Painful Bladder Syndrome Flares
FRIDAY, Oct. 22 (HealthDay News) -- Episodes of bacteria in the urine (bacteriuria) do not seem to be related to symptoms of painful bladder syndrome (PBS) in women with interstitial cystitis (IC), according to a study in the October issue of Urology.
Low Testosterone Linked With CVD-Related Mortality
FRIDAY, Oct. 22 (HealthDay News) -- New research suggests a link between low testosterone levels and increased risk of death in men who have heart disease, according to a report published online Oct. 19 in Heart.
FDA to Update Prescribing Labels of GnRH Agonists
THURSDAY, Oct. 21 (HealthDay News) -- The U.S. Food and Drug Administration has notified health care professionals and consumers that the prescribing labels of gonadotropin-releasing hormone (GnRH) agonists will be updated with new safety information.
Estrogen Replacement Raises Kidney Stone Risk
TUESDAY, Oct. 12 (HealthDay News) -- Estrogen therapy appears to significantly increase the risk of kidney stone formation in healthy postmenopausal women, according to research published Oct. 11 in the Archives of Internal Medicine.
Collaboration Required for Better Testosterone Assays
MONDAY, Oct. 11 (HealthDay News) -- Improving testosterone assays for better measurement of testosterone levels will require a multipronged approach involving all parties concerned with achieving this goal, according to a consensus statement published in the October issue of The Journal of Clinical Endocrinology and Metabolism.
Usual Prostate Cancer Therapy Linked to Bone Deterioration
FRIDAY, Oct. 8 (HealthDay News) -- Androgen deprivation therapy (ADT) for prostate cancer is associated with bone deterioration, and a new technology may help identify men at risk for fractures related to this deterioration, according to a study published online Sept. 29 in the Journal of Clinical Endocrinology & Metabolism.
Quality of Life Varies by Prostate Cancer Treatment
FRIDAY, Oct. 8 (HealthDay News) -- Radical prostatectomy, external-beam radiotherapy, and brachytherapy result in several quality-of-life (QoL) issues after prostate cancer treatment in patients not receiving adjuvant hormonal treatment, including either improvement in or worsening of urinary irritative-obstructive symptoms in addition to the more commonly discussed sexual and incontinence issues, according to research published online Oct. 4 in the Journal of Clinical Oncology.
Cabazitaxel Prolongs Life in Advanced Prostate Cancer
FRIDAY, Oct. 1 (HealthDay News) -- Men with advanced prostate cancer that has resisted prior chemotherapy with docetaxel survive a median 2.4 months longer if they take cabazitaxel instead of mitoxantrone, according to the results of a phase III trial published in the Oct. 2, cancer-themed issue of The Lancet.
Genetic Mutation Explains Some Male Infertility
FRIDAY, Oct. 1 (HealthDay News) -- A genetic mutation may explain sperm production failure in about 4 percent of infertile but otherwise healthy men, according to research published online Sept. 30 in the American Journal of Human Genetics.